| 发明名称 |
PROTEOMIC IPF MARKERS |
| 摘要 |
Provided herein are novel biomarkers for the identification, prediction or monitoring of fibrotic pulmonary diseases (e.g. idiopathic pulmonary fibrosis (IPF)). The biomarkers provided herein may further be used for therapeutic treatment of IPF. |
| 申请公布号 |
US2014286929(A1) |
申请公布日期 |
2014.09.25 |
| 申请号 |
US201414213970 |
申请日期 |
2014.03.14 |
| 申请人 |
Intermune, Inc. |
发明人 |
Kossen Karl;Qin Xiaoli;Lim Sharlene R.;Seiwert Scott S.;Ruhrmund Donald |
| 分类号 |
G01N33/543;A61K38/45;A61K38/46;A61K38/17;A61K38/48 |
主分类号 |
G01N33/543 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method of determining an expression level of a fibrotic pulmonary disease marker protein set forth in Table 2A or Table 2B in a subject that has or is at risk for developing a fibrotic pulmonary disease, said method comprising:
(i) obtaining a biological sample from said subject; and (ii) determining an expression level of a fibrotic pulmonary disease marker protein set forth in Table 2A or Table 2B in said biological sample. |
| 地址 |
Brisbane CA US |
